Key To Stopping Growth And Migration Of Brain Cancer Cells Is Cell Signaling
1/19/2012
Brain cancer is hard to treat: it's not only strong enough to resist most chemotherapies, but also nimble enough to migrate away from radiation or surgery to regrow elsewhere. New research at the University of Colorado Cancer Center shows how to stop both. Specifically, cells signal themselves to survive, grow, reproduce, and migrate...
Cost To The Nation For Job-Related Injuries And Illnesses Estimated At $250 Billion Per Year
1/19/2012
In the first comprehensive review of its kind since 1992, a UC Davis researcher has estimated the national annual price tag of occupational injuries and illnesses at $250 billion, much higher than generally assumed. That figure is $31 billion more than the direct and indirect costs of all cancer, $76 billion more than diabetes and $187 billion more than strokes...
Potential New Approach For Treating Graft-Versus-Host-Disease Provided By Natural Enzyme
1/19/2012
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants. Researchers from the University of Michigan Comprehensive Cancer Center looked at the drug alpha-1-antitrypsin, which is approved by the U.S...
Identification Of Essential Protein For The Formation Of New Blood Vessels
1/19/2012
New research explains how cells regulate their bonds during the development of new blood vessels. For the first time, the role of the protein Raf-1 in determining the strength of the bond between cells has been shown. If Raf-1 is not present, the cells cannot stick together and the formation of new blood vessels is inhibited...
Malignant Melanoma Recurrence - How To Avoid It After Targeted Treatment
1/18/2012
According to a study published in the New England Journal of Medicine, researchers at The Institute of Cancer Research (ICR) have demonstrated how to prevent new cancers that can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors...
Blood Clots After Hip Or Knee Replacement - Study Looks At Prevalence
1/18/2012
According to a study in the January 18 issue of JAMA, approximately 1 in every 100 patients undergoing knee replacement surgery, and 1 in every 200 patients undergoing hip replacement surgery who use current preventive medications for venous thromboembolism (VTE; a blood clot that develops within a vein that might become serious), will develop VTE before being discharged from hospital...
Drug Helps Maintain Platelet Inhibition And Anti-Clotting Levels Prior To Cardiac Surgery
1/18/2012
According to a study in the January 18 issue of JAMA, patients who stop using an antiplatelet agent, such as clopidogrel, before undergoing cardiac surgery to reduce their risk of bleeding and received intravenously the platelet inhibitor cangrelor, achieved a higher rate of maintenance of platelet inhibition than those who were given placebo...
Malignant Melanoma Recurrence - How To Avoid It After Targeted Treatment
1/18/2012
According to a study published in the New England Journal of Medicine, researchers at The Institute of Cancer Research (ICR) have demonstrated how to prevent new cancers that can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors...
Stopping Prostate Cancer Growth - Breakthrough
1/18/2012
A study by investigators at the Methodist Research Institute at Indiana University confirms that an all-natural, doctor-designed formula is effective in suppressing prostate cancer tumors. The study conducted on mice, used a human prostate cancer xenograft model. Results from the live animal study were presented by lead researcher, Dr...
Scriptaid Revives Breast Cancer Treatment Receptivity
1/18/2012
A study by researchers from the Sbarro Institute for Cancer Research and Molecular Medicine, reveals that despite the effectiveness of endocrine therapy for breast cancer, responsiveness to the treatment depends on expression of estrogen receptors in breast cancer cells. However, Dr...